Literature DB >> 20056195

When do trauma experts choose exposure therapy for PTSD patients? A controlled study of therapist and patient factors.

Agnes van Minnen1, Lotte Hendriks, Miranda Olff.   

Abstract

To investigate when and why therapists opt for or rule out imaginal exposure (IE) for patients with posttraumatic stress disorder (PTSD), 255 trauma experts were randomized to two conditions in which they were presented with four cases in which the patients' comorbidity and treatment preferences were manipulated. The results confirmed IE to be an underutilized approach, with the majority of professionals being undertrained in the technique. As predicted, the patient factors influenced the expert's choice of therapy: in case of a comorbid depression, IE was significantly less preferred than medication. Also, IE was significantly more likely to be offered when patients expressed a preference for trauma-focused treatment. The therapist factors were also found to be importantly related to treatment preferences, with high credibility in the technique being positively related to the therapists' preference for IE. Perceived barriers to IE, such as a fear of symptom exacerbation and dropout, were negatively related to the perceived suitability of the treatment when patients had suffered multiple traumas in childhood. The results are discussed in the light of clinical implications and the need of exposure training for trauma professionals. 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20056195     DOI: 10.1016/j.brat.2009.12.003

Source DB:  PubMed          Journal:  Behav Res Ther        ISSN: 0005-7967


  61 in total

1.  Challenges and Successes in Dissemination of Evidence-Based Treatments for Posttraumatic Stress: Lessons Learned From Prolonged Exposure Therapy for PTSD.

Authors:  Edna B Foa; Seth J Gillihan; Richard A Bryant
Journal:  Psychol Sci Public Interest       Date:  2013-05

2.  Perspectives on a Stage-Based Treatment for Posttraumatic Stress Disorder Among Dialectical Behavior Therapy Consumers in Public Mental Health Settings.

Authors:  Melanie S Harned; Sara C Schmidt
Journal:  Community Ment Health J       Date:  2018-12-07

Review 3.  An empirical review of potential mediators and mechanisms of prolonged exposure therapy.

Authors:  Andrew A Cooper; Erin G Clifton; Norah C Feeny
Journal:  Clin Psychol Rev       Date:  2017-07-11

4.  Therapeutic alliance across trauma-focused and non-trauma-focused psychotherapies among veterans with PTSD.

Authors:  Jessica A Chen; John C Fortney; Hannah E Bergman; Kendall C Browne; Kathleen M Grubbs; Teresa J Hudson; Patrick J Raue
Journal:  Psychol Serv       Date:  2019-02-11

5.  Teaching Trauma-Focused Exposure Therapy for PTSD: Critical Clinical Lessons for Novice Exposure Therapists.

Authors:  Lori A Zoellner; Norah C Feeny; Joyce N Bittinger; Michele A Bedard-Gilligan; David M Slagle; Loren M Post; Jessica A Chen
Journal:  Psychol Trauma       Date:  2011-09-01

6.  Provider general attitudes versus specific perceptions of evidence-based psychotherapies for PTSD.

Authors:  Joan M Cook; Richard Thompson; Vanessa Simiola; Shannon Wiltsey Stirman; Paula P Schnurr
Journal:  Psychol Serv       Date:  2018-09-27

7.  Predicting adoption of exposure therapy in a randomized controlled dissemination trial.

Authors:  Melanie S Harned; Linda A Dimeff; Eric A Woodcock; Ignacio Contreras
Journal:  J Anxiety Disord       Date:  2013-03-04

8.  Treatment preference among suicidal and self-injuring women with borderline personality disorder and PTSD.

Authors:  Melanie S Harned; Mathew A Tkachuck; Kelly A Youngberg
Journal:  J Clin Psychol       Date:  2013-02-26

9.  Depression sudden gains and transient depression spikes during treatment for PTSD.

Authors:  Stephanie M Keller; Norah C Feeny; Lori A Zoellner
Journal:  J Consult Clin Psychol       Date:  2013-12-23

10.  Mental Health Providers' Decision-Making Around the Implementation of Evidence-Based Treatment for PTSD.

Authors:  Princess E Osei-Bonsu; Rendelle E Bolton; Shannon Wiltsey Stirman; Susan V Eisen; Lawrence Herz; Maura E Pellowe
Journal:  J Behav Health Serv Res       Date:  2017-04       Impact factor: 1.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.